{"transactions":[{"id":1670352,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-26T21:01:19.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 28, 2023, the reporting person was awarded 20,000 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 8,500 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 2,834 units, 2,833 units, and 2,833 units on each of September 28, 2024, September 28, 2025 and September 28, 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":80436,"source":{"system":"sec-edgar","filing":"0001477932-24-000400","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224000400/form4.xml","form_type":"4"}},{"id":1729233,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-28T14:39:23.000Z","date":"2023-11-27","kind":"purchase","planned":false,"acquired":true,"shares":9000,"price":0.8,"value":7200.0,"ownership":{"direct":true},"balance_after":71936,"source":{"system":"sec-edgar","filing":"0001477932-23-008821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223008821/form4.xml","form_type":"4"}},{"id":1797269,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-25T15:49:30.000Z","date":"2023-08-24","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.22,"value":6100.0,"ownership":{"direct":true},"balance_after":62936,"source":{"system":"sec-edgar","filing":"0001477932-23-006469","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223006469/form4.xml","form_type":"4"}},{"id":1833379,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-07T20:02:04.000Z","date":"2023-07-05","kind":"grant","planned":false,"acquired":true,"shares":6750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 15,000 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 6,750 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 2,250 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in October 2022 and January 2023 respectively, the rights with respect to 2,625 RSUs and 5,625 RSUs subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":57936,"source":{"system":"sec-edgar","filing":"0001477932-23-005115","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223005115/form4.xml","form_type":"4"}},{"id":2055272,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-13T21:01:34.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":5625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 5,625 restricted stock units vesting.  The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 1,875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.  As reported in October 2022, the rights with respect to 2,625 restricted stock units subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":51186,"source":{"system":"sec-edgar","filing":"0001477932-23-000263","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223000263/form4.xml","form_type":"4"}},{"id":2137431,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-14T20:11:40.000Z","date":"2022-10-13","kind":"grant","acquired":true,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 2,625 restricted stock units vesting.  The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":45561,"source":{"system":"sec-edgar","filing":"0001477932-22-007706","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222007706/form4.xml","form_type":"4"}},{"id":2222606,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T20:04:57.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":5613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 3, 2021, the reporting person was granted an option to purchase 8,635 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 5,613 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two installments of 2,807 shares and 2,806 shares on each of August 3, 2022 and August 3, 2023, respectively.  As reported in April 2022, the rights with respect to the remaining 3,022 shares subject to the award previously vested and remain subject to time-based vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On August 3, 2021, the reporting person was granted an option to purchase 8,635 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 5,613 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two installments of 2,807 shares and 2,806 shares on each of August 3, 2022 and August 3, 2023, respectively.  As reported in April 2022, the rights with respect to the remaining 3,022 shares subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":8653,"derivative":{"exercise_price":3.4,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":5613},"source":{"system":"sec-edgar","filing":"0001477932-22-004664","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222004664/form4.xml","form_type":"4"}},{"id":2222605,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T20:04:57.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":3046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 3, 2021, the reporting person was awarded 4,686 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 3,046 restricted stock units vesting.  The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two equal installments of 1,523 units on each of August 3, 2022 and August 3, 2023, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in April 2022, the rights with respect to the remaining 1,640 restricted stock units subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":42936,"source":{"system":"sec-edgar","filing":"0001477932-22-004664","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222004664/form4.xml","form_type":"4"}},{"id":2300897,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-08T20:05:08.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":3022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 3, 2021, the reporting person was granted an option to purchase 8,635 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 3,022 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 1,511 shares on each of August 3, 2022 and August 3, 2023, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On August 3, 2021, the reporting person was granted an option to purchase 8,635 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 3,022 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 1,511 shares on each of August 3, 2022 and August 3, 2023, respectively."}],"balance_after":3022,"derivative":{"exercise_price":3.4,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":3022},"source":{"system":"sec-edgar","filing":"0001477932-22-002186","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222002186/form4.xml","form_type":"4"}},{"id":2300896,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T20:05:08.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":1640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 3, 2021, the reporting person was awarded 4,686 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 1,640 restricted stock units vesting.  The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two equal installments of 820 units on each of August 3, 2022 and August 3, 2023, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":39890,"source":{"system":"sec-edgar","filing":"0001477932-22-002186","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222002186/form4.xml","form_type":"4"}},{"id":2524039,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:05:36.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options. The \"old\" options were originally granted on January 23, 2018, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on January 23, 2028 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options. The \"old\" options were originally granted on January 23, 2018, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on January 23, 2028 (ten years from the original date of grant)."}],"balance_after":10000,"derivative":{"exercise_price":4,"exercise_date":"2019-01-23","expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001477932-21-007864","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221007864/form4.xml","form_type":"4"}},{"id":2524038,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:05:36.000Z","date":"2021-11-03","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options. The \"old\" options were originally granted on January 23, 2018, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on January 23, 2028 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options. The \"old\" options were originally granted on January 23, 2018, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on January 23, 2028 (ten years from the original date of grant)."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2019-01-23","expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001477932-21-007864","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221007864/form4.xml","form_type":"4"}},{"id":2524037,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:05:36.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options. The \"old\" options were originally granted on March 30, 2017, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on March 30, 2027 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options. The \"old\" options were originally granted on March 30, 2017, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on March 30, 2027 (ten years from the original date of grant)."}],"balance_after":15000,"derivative":{"exercise_price":5,"exercise_date":"2018-03-30","expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001477932-21-007864","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221007864/form4.xml","form_type":"4"}},{"id":2524036,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:05:36.000Z","date":"2021-11-03","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options. The \"old\" options were originally granted on March 30, 2017, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on March 30, 2027 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options. The \"old\" options were originally granted on March 30, 2017, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on March 30, 2027 (ten years from the original date of grant)."}],"balance_after":0,"derivative":{"exercise_price":5,"exercise_date":"2018-03-30","expiration_date":"2023-03-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001477932-21-007864","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221007864/form4.xml","form_type":"4"}},{"id":2524035,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:05:36.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of 'replacement\" options. The \"old\" options were originally granted on June 23, 2016, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on June 23, 2026 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of 'replacement\" options. The \"old\" options were originally granted on June 23, 2016, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on June 23, 2026 (ten years from the original date of grant)."}],"balance_after":15000,"derivative":{"exercise_price":4,"exercise_date":"2017-06-23","expiration_date":"2026-06-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001477932-21-007864","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221007864/form4.xml","form_type":"4"}},{"id":2524034,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:05:36.000Z","date":"2021-11-03","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of 'replacement\" options. The \"old\" options were originally granted on June 23, 2016, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on June 23, 2026 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of 'replacement\" options. The \"old\" options were originally granted on June 23, 2016, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on June 23, 2026 (ten years from the original date of grant)."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2017-06-23","expiration_date":"2022-06-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001477932-21-007864","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221007864/form4.xml","form_type":"4"}},{"id":3177012,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-15T21:23:11.000Z","date":"2020-04-13","kind":"grant","acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Dr. Futcher received restricted stock units subject to a 2-year vesting schedule, vesting as to 5,625 units on each of 04/13/21 and 04/13/22, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":38250,"source":{"system":"sec-edgar","filing":"0001078782-20-000268","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000268/primary_doc.xml","form_type":"4"}},{"id":3662020,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-13T21:36:46.000Z","date":"2019-02-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A total of 15,000 Options were granted on February 11, 2019 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":3.25,"exercise_date":"2020-02-11","expiration_date":"2025-02-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001078782-19-000131","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878219000131/primary_doc.xml","form_type":"4"}},{"id":4090523,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-25T21:28:20.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A total of 10,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan.  The Options vest in full twelve months from the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":4,"exercise_date":"2019-01-23","expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001078782-18-000067","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878218000067/primary_doc.xml","form_type":"4"}},{"id":4366213,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":94892,"kind":"person","name":"Futcher Edward","position":1,"cik":"0001222623","reported_name":"Futcher Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-03T20:23:54.000Z","date":"2017-03-30","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A total of 15,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan.  The Options vest in full twelve months from the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":5,"exercise_date":"2018-03-30","expiration_date":"2023-03-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001078782-17-000410","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878217000410/primary_doc.xml","form_type":"4"}}]}